FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2167496270> ?p ?o ?g. }

• W2167496270 endingPage "2900" @default.
• W2167496270 startingPage "2894" @default.
• W2167496270 abstract "Summary Background and objectives Rituximab and intravenous Ig (IVIG) are commonly used for desensitization of HLA and blood group–incompatible (ABOi) transplants. However, serious infections have been noted in association with rituximab administration. In this study, we retrospectively compared infectious outcomes in those who received rituximab plus IVIG for HLA or ABOi transplants (RIT group) with a group of nonsensitized, ABO-compatible transplant recipients (non-RIT group). Design, setting, participants, & measurements Patients undergoing kidney transplantation at Cedars-Sinai Medical Center were included in the analysis. A total of 361 patients were identified. All received antimicrobial prophylaxis and viral surveillance. The primary outcome was infection. Results Overall patient survival was 97 and 96%, and graft survival was 91 and 89% in the RIT and non-RIT groups, respectively, after an average follow-up of 18 months. There were equal rates of bacterial (34.7% versus 39.1%), viral (21.8% versus 25.1%), fungal (5.9% versus 5.2%), and serious infections (22.9% versus 25.5%) in the RIT and non-RIT groups respectively. Urinary tract infection was the most common infection, accounting for 50% of all bacterial infections. Cytomegalovirus viremia was nonsignificantly more common in the nonrituximab-treated group (15.2% versus 10%), whereas BK viremia was marginally more frequent in the rituximab-treated group (10.6% versus 5.8%). There were no graft losses caused by BK-associated nephropathy. There were two deaths in each group related to infection (1%). Conclusion Rituximab does not increase infection risk when used with intravenous Ig for desensitization." @default.
• W2167496270 created "2016-06-24" @default.
• W2167496270 creator A5002039083 @default.
• W2167496270 creator A5021943951 @default.
• W2167496270 creator A5036281463 @default.
• W2167496270 creator A5044616722 @default.
• W2167496270 creator A5047499121 @default.
• W2167496270 creator A5047515692 @default.
• W2167496270 creator A5067740422 @default.
• W2167496270 creator A5071314630 @default.
• W2167496270 creator A5072310025 @default.
• W2167496270 creator A5076738806 @default.
• W2167496270 creator A5082190685 @default.
• W2167496270 date "2011-12-01" @default.
• W2167496270 modified "2023-10-16" @default.
• W2167496270 title "Infectious Complications in Kidney-Transplant Recipients Desensitized with Rituximab and Intravenous Immunoglobulin" @default.
• W2167496270 cites W1510382284 @default.
• W2167496270 cites W1692050915 @default.
• W2167496270 cites W1968102557 @default.
• W2167496270 cites W1987068568 @default.
• W2167496270 cites W1994630947 @default.
• W2167496270 cites W2006326109 @default.
• W2167496270 cites W2016551261 @default.
• W2167496270 cites W2018110742 @default.
• W2167496270 cites W2022620519 @default.
• W2167496270 cites W2025611037 @default.
• W2167496270 cites W2041085325 @default.
• W2167496270 cites W2054799814 @default.
• W2167496270 cites W2059446551 @default.
• W2167496270 cites W2059789494 @default.
• W2167496270 cites W2066807553 @default.
• W2167496270 cites W2067697951 @default.
• W2167496270 cites W2076231102 @default.
• W2167496270 cites W2080919481 @default.
• W2167496270 cites W2082062651 @default.
• W2167496270 cites W2085915009 @default.
• W2167496270 cites W2092628378 @default.
• W2167496270 cites W2111998374 @default.
• W2167496270 cites W2131621311 @default.
• W2167496270 cites W2139856839 @default.
• W2167496270 cites W2149292379 @default.
• W2167496270 cites W2160909371 @default.
• W2167496270 doi "https://doi.org/10.2215/cjn.03710411" @default.
• W2167496270 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3255382" @default.
• W2167496270 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22157713" @default.
• W2167496270 hasPublicationYear "2011" @default.
• W2167496270 type Work @default.
• W2167496270 sameAs 2167496270 @default.
• W2167496270 citedByCount "83" @default.
• W2167496270 countsByYear W21674962702012 @default.
• W2167496270 countsByYear W21674962702013 @default.
• W2167496270 countsByYear W21674962702014 @default.
• W2167496270 countsByYear W21674962702015 @default.
• W2167496270 countsByYear W21674962702016 @default.
• W2167496270 countsByYear W21674962702017 @default.
• W2167496270 countsByYear W21674962702018 @default.
• W2167496270 countsByYear W21674962702019 @default.
• W2167496270 countsByYear W21674962702020 @default.
• W2167496270 countsByYear W21674962702021 @default.
• W2167496270 countsByYear W21674962702022 @default.
• W2167496270 countsByYear W21674962702023 @default.
• W2167496270 crossrefType "journal-article" @default.
• W2167496270 hasAuthorship W2167496270A5002039083 @default.
• W2167496270 hasAuthorship W2167496270A5021943951 @default.
• W2167496270 hasAuthorship W2167496270A5036281463 @default.
• W2167496270 hasAuthorship W2167496270A5044616722 @default.
• W2167496270 hasAuthorship W2167496270A5047499121 @default.
• W2167496270 hasAuthorship W2167496270A5047515692 @default.
• W2167496270 hasAuthorship W2167496270A5067740422 @default.
• W2167496270 hasAuthorship W2167496270A5071314630 @default.
• W2167496270 hasAuthorship W2167496270A5072310025 @default.
• W2167496270 hasAuthorship W2167496270A5076738806 @default.
• W2167496270 hasAuthorship W2167496270A5082190685 @default.
• W2167496270 hasBestOaLocation W21674962701 @default.
• W2167496270 hasConcept C126322002 @default.
• W2167496270 hasConcept C159654299 @default.
• W2167496270 hasConcept C176080213 @default.
• W2167496270 hasConcept C203014093 @default.
• W2167496270 hasConcept C2776185481 @default.
• W2167496270 hasConcept C2779338263 @default.
• W2167496270 hasConcept C2780303639 @default.
• W2167496270 hasConcept C2780653079 @default.
• W2167496270 hasConcept C2911091166 @default.
• W2167496270 hasConcept C71924100 @default.
• W2167496270 hasConcept C77411442 @default.
• W2167496270 hasConcept C90924648 @default.
• W2167496270 hasConceptScore W2167496270C126322002 @default.
• W2167496270 hasConceptScore W2167496270C159654299 @default.
• W2167496270 hasConceptScore W2167496270C176080213 @default.
• W2167496270 hasConceptScore W2167496270C203014093 @default.
• W2167496270 hasConceptScore W2167496270C2776185481 @default.
• W2167496270 hasConceptScore W2167496270C2779338263 @default.
• W2167496270 hasConceptScore W2167496270C2780303639 @default.
• W2167496270 hasConceptScore W2167496270C2780653079 @default.
• W2167496270 hasConceptScore W2167496270C2911091166 @default.
• W2167496270 hasConceptScore W2167496270C71924100 @default.
• W2167496270 hasConceptScore W2167496270C77411442 @default.
• W2167496270 hasConceptScore W2167496270C90924648 @default.

• next